American College of Cardiology annual meeting: Drug improves heart attack treatment
American College of Cardiology annual meeting,March 6–9, Orlando
Drug improves heart attack treatment
The hard-working duet of aspirin and a clot-buster, long the mainstays of treating a heart attack, will probably expand into a trio. The addition of Plavix, a kind of superaspirin, for a few days boosts survival rates and helps limit second heart attacks and strokes, according to two studies that included almost 50,000 volunteers from China and 23 other countries.
Plavix (clopidogrel) makes it harder for platelets to cause blood clots, which are the underlying cause of most heart attacks and strokes. Some hospitals have already been using the drug for people in the midst of a heart attack. The two studies presented at the American College of Cardiology meeting will likely increase this use of Plavix.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
